CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors
Conferences
Logan, K; Huang, J; Morse, M; Shi, C
Published in: MODERN PATHOLOGY
March 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MODERN PATHOLOGY
EISSN
1530-0285
ISSN
0893-3952
Publication Date
March 2022
Volume
35
Start / End Page
488 / 489
Related Subject Headings
- Pathology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Logan, K., Huang, J., Morse, M., & Shi, C. (2022). CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. In MODERN PATHOLOGY (Vol. 35, pp. 488–489).
Logan, Kristen, Jiaoti Huang, Michael Morse, and Chanjuan Shi. “CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors.” In MODERN PATHOLOGY, 35:488–89, 2022.
Logan K, Huang J, Morse M, Shi C. CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. In: MODERN PATHOLOGY. 2022. p. 488–9.
Logan, Kristen, et al. “CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors.” MODERN PATHOLOGY, vol. 35, 2022, pp. 488–89.
Logan K, Huang J, Morse M, Shi C. CXCR2 is Highly Expressed in Gastroenteropancreatic Neuroendocrine Tumors. MODERN PATHOLOGY. 2022. p. 488–489.
Published In
MODERN PATHOLOGY
EISSN
1530-0285
ISSN
0893-3952
Publication Date
March 2022
Volume
35
Start / End Page
488 / 489
Related Subject Headings
- Pathology
- 3202 Clinical sciences